Stay updated on AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check24 days agoChange DetectedThe page footer now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page footer now shows Revision: v3.4.2, replacing the previous Revision: v3.4.1.SummaryDifference0.1%

- Check60 days agoChange DetectedSite revision updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedA 'Show glossary' toggle was added, the QC update label was changed to 'Last Update Submitted that Met QC Criteria', and a 'No FEAR Act Data' notice along with revision v3.4.0 was added.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page, a minor metadata change that does not affect study content or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104+Lenvatinib in Advanced Hepatocellular Carcinoma Clinical Trial page.